Patents Assigned to ZENOBIA THERAPEUTICS, INC.
  • LRRK2 INHIBITORS
    Publication number: 20140205537
    Abstract: Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
    Type: Application
    Filed: June 22, 2012
    Publication date: July 24, 2014
    Applicant: ZENOBIA THERAPEUTICS, INC.
    Inventors: Pierre-Yves Bounaud, Vicki Nienaber, Ruo W. Steensma, John A. Lowe, III